Background: There is no large-scale data on the management practices and in-hospital outcomes of acute coronary syndromes (ACS) in Bangladesh. This study aimed to document the presentation characteristics, treatment practices and in-hospital outcomes of ACS patients presenting to a specialized tertiary cardiac care institute in Bangladesh. 
Introduction
Cardiovascular disease (CVD) is a growing epidemic in South Asia, and is the leading cause of mortality in the Indian subcontinent 1 , as well as Bangladesh 2 .Acute coronary syndromes (ACS) are responsible for a large number of individuals with atherothrombotic cardiovascular disease than any other region by the year 2020 1 . Most notable features of CAD in South Asian populations are extreme prematurity, increased severity, hospitalization and mortality 2, 3 .
The current understanding of the aetiology of ACS involves plaque erosion or rupture in response to inflammation, leading to local occlusive or non-occlusive thrombus 4 . Depending on the degree and reversibility of this dynamic obstruction, the clinical manifestations of ACS comprise a continuous spectrum of risk that progresses from unstable angina (UA) to non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI) 5 .
A number of national and multi-national registries across the globe, including in Asia, have investigated the clinical characteristics and treatment-related outcomesamong ACS patients . These data have shown regional variation in the clinical presentations, use of invasive procedures and outcomes across the spectrum of ACS, across different regions of the world.In the South Asian region, two large registries in India [7] [8] have documented the demographic characteristics, treatment practices and outcomes of ACS patients.
There are limited data onthe presentation and outcomes of ACS from Bangladesh, with most of the studies being small ones, restricted to a particular subset of ACS patients [27] [28] [29] .A large-scale ACS registry of Bangladeshi patients is a timely necessity. This study aimed to document the characteristics, treatment practices and outcomes of ACS patients presenting to a tertiary cardiac care institute in Bangladesh.
Methods
Patient population and definitions: This was a crosssectional retrospective analysis of all patients who presented with the diagnosis of ACS to Ibrahim Cardiac Hospital & Research Institute (ICHRI), Dhaka, Bangladesh. All consecutive patients with a final diagnosis of ACS comprising of either STEMI, NSTEMI and UA were included in the study. Diagnosis of the different types of ACS and definitions of data variables and outcomes were based on ACCF/ AHA data standards 30 .
Data collection: Demographic characteristics, risk factors, baseline clinical parameters, treatment modalities and medication administered, angiographic profiles, revascularization techniques and in-hospital outcomes were documented on a case report form (CRF) by study investigators. Data were derived from hospital in-patient clinical notes, discharge summaries and cardiac catheterization laboratory database.
Statistical analysis: Data analyses were carried out using Statistical Package for Social Sciences(SPSS) version 16.0 (Chicago, Illinois, USA). Continuous variables were expressed as mean ± standard deviation, and compared using the Student's t-test and ANOVA statistics. Categorical variables were expressed as number with corresponding percentage, and compared using the chi-square test.A p value < 0.05 was considered statistically significant.
Ethical approval: The study complied with the Declaration of Helsinki and ethical approval was obtained by the ethical review committee of ICHRI, Dhaka, Bangladesh.
Results

Demographic characteristics, key risk factors, and clinical presentation
A total 5502 patients were admitted during the period from January 2013 to December 2013, of whom 1914 (34.8%) presented withACS.The demographic details and baseline patient characteristics are presented in Table 1 . The mean age of participants was 57.8 ± 12.1 (range 21-97) years. The majority of the patients (51.7%) were between the ages of 45-64 years, with 17.1% <45 years of age. 1366 patients(71.4%) were male. Almost equal numbers of patients presented with STEMI and NSTEMI (39.8% and 39.7% respectively). 392 (20.5%) patients presented with UA. Diabetes (68.91%), hypertension (74.24%) and dyslipidaemia (53.23%) were the leading risk factors for CAD. Smoking and stroke were more common among patients with STEMI (p<0.001). Diabetes, prior myocardial infarction (MI) and chronic kidney disease (CKD)were significantly more frequent among those presenting with NSTEMI, while prior percutaneous coronary intervention (PCI), prior coronary artery bypass graft (CABG) surgery and hypertension were more common among those presenting with UA (p<0.001). 79.5% of patients had positive cardiac biomarkers at presentation. 79.1% of patients presented with chest pain, a symptom which was approximately equally observed across the whole spectrum of ACS, albeit slightly lesser among those with NSTEMI (42.3%). However, NSTEMIpatients tended to present the most frequently with dyspnoea (42.3%) in comparison with STEMI (24.5%) and UA patients (28.3%). This was reflected further by the increased incidence of left ventricular failure (31.9%) seen among NSTEMI patients.
In-hospital diagnostic evaluations and management 1022 (53.4%) of the 1914 admitted ACS patients underwent coronary angiography during index hospitalisation.Left main stenosis >50% and severe graft vessel stenosis was observed significantly more among NSTEMI patients (3.4% and 1.3% respectively, p<0.001). Significant stenosis of left anterior descending (LAD) and right coronary artery (RCA) were seen most frequently among STEMI patients (Table 2 ). Multivariate analysis revealed that age >50 years, CKD, bradycardia on admission, shock, LVF, admission with dyspnoea and STEMI were independent predictors of inhospital mortality (Table 5) Discharge medical therapy and prescriptions: 95.5% of ACS patients received aspirin at discharge, 93.2% in whom it was prescribed as a component of dual antiplatelet therapy (DAPT) ( Table 6 ). Statins (82.8%) and 
Discussion
To the best of our knowledge, these data represent the largest contemporary ACS registry in Bangladesh, to date.
It provides insight into the descriptive epidemiology, practice patterns and in-hospital outcomes of Bangladeshi ACS patients presenting to a tertiary cardiac centre. Table 7 represents a comparison of characteristics of ACS patients from different registries worldwide.
The mean age of our subjects was a relatively young age of 57.8 ± 12.1 years, which is comparable with those of the CREATEand middle eastern registries (GulfRACE and SPACE) 7, 16, 17 ,marginally lower than the Kerala ACS registry 8 and ACCESS registry 21 , but significantly younger than those of Thai ACSRegistry, GRACE, ACTION AR-G and other European registries 13, 18, [22] [23] [24] , reflecting the younger presentation of ACS among Bangladeshis.
Approximately three-fourths of our ACS population was male, an observation seen across all ACS registries worldwide. In terms of risk factor distribution, 74.2% had hypertension, 68.9% had diabetes, 53.2% had dyslipidaemia and 25.8% had a history of smoking. These rates of smoking may be underestimated owing to lack of data in some patient records. Hypertension,diabetes and dyslipidaemia showed much greater incidence in our population in comparison to other Asian and Western registries. In fact, the incidence of diabetes we report may be one of the highest rates of diabetes in an ACS population, which is triple the rates reported in the multinational GRACE registry 18, 19 , and almost double the rates reported in Indian studies 7, 8 . The presence of CKD, an additional risk factor contributing to poor outcome, was as high as 20.7% in this ACS population, possibly linked to the high prevalence of concomitant diabetes and hypertension. CKD has not been welldocumented in other ACS registries, however, we found in our study that CKD posed significant mortality risk (odds ratio 2.1, p<0.001). The clustering of these co-morbidities may be responsible for ACS presentation at a much younger age in our population, as well as for the marginally increased overall mortality rate observed in our registry. Similarly, in a sub analysis of Gulf RACE registry, diabetic patients presenting with ACS were more likely to have a clustering of additional co-morbidities and were at risk of more adverse non-fatal hospital outcomes 31 .
In this study, STEMI patientswere younger than those with NSTE-ACS. They had fewer risk factors, and a less frequent history of prior cardiac disease or intervention; they were, however, more often smokers, and significantly higher inhospital mortality rate, compared to NSTEMI. These findings reflect those observed in regional registries such as CREATE, Kerala ACS and ACCESS 7, 8, 21 , as well as those from high income countries (AR-G registries-ACS II registries) [22] [23] [24] , reflecting a pattern of a generally greater co-morbidities and higher number of risk factors among NSTE-ACS patients.
There was almost equal presentation of STEMI and NSTEMI as admission diagnosis, in this series. This is in contrast to most Asian registries and the GRACE registry, where STEMI was the most common presentation of ACS 7, 8, 11, 13, 16 . In both the Euro Heart Surveys, SPACE registry and a more contemporary Indian study, NSTEMI was the more common diagnosis 9, 16, 22, 23 .53.4% of all ACS patients in our registry underwent coronary angiography. This is comparable with GRACE and Euro-Heart SurveryACS-Iregistry 18, 22, 23 , and significantly higher in comparison to Indian registries, as well as Gulf RACE 7, 8, 16 . The higher angiographic rates could largely be driven by the relatively more affluent socioeconomic status of patients being admitted in this hospital, as well as the more contemporary nature of our data. A PCI rate of 26.6% is also higher than other registries in the region, albeit substantially lower than Middle Eastern and Western registries (Table7). 43% of patients who underwent PCI had presented with STEMI, among whom only 6.2% underwent primary PCI. This relatively lower rate is comparable to Gulf RACE and Malaysian NCVD ACS registry 11, 16 , but is staggeringly lower than rates of high income countries. Explanations for this lower rate are multifactorial: it may be due to the unavailability of primary PCI facilities during night hours, and also due to educational and cultural factors such as patient refusal to undergo an 'invasive' procedure immediately after admission, preferring a more conservative approach in the initial days of admission.
However, a much higher number of overall STEMI patients undergoing PCI were given a DES (84.3%), in comparison to 39% in ACCESS and 26% in GRACE 18, 21 . Of the 5.5% in whom primary PCI was done, 85.4% received a DES. This may reflect the more contemporary nature of our data and the increased use of DES over time.
93.2% of our patients received DAPT at discharge, among whom 85% were given clopidogrel, and 12.7% prasugrel as P2Y12 blocker. Compared with the Kerala registry, patients in our study were more likely to receive most key evidencebased ACS medications on discharge prescriptions, except beta-blockers, which were prescribed less (47.3% vs 62.7% in Kerala registry) 8 .The lower rates of prasugrel reflect a new entry of the drug into the local arena;ticagrelor was unavailable in the country during the time of this study.
The overall in-hospital mortality rate of 7.6% is comparable to data from CREATE 7 and the Malaysian NCVD registry 11 , but higher than those observed in registries from high income countries, and the Kerala registry 8 . This may be due to the increased prevalence and clustering of more than one cardiovascular risk factor among study subjects. Although NSTE-ACS patients had worse prior histories and more risk factors, their mortality was lower than STEMI patients, reflecting similar observations of prior studies 21 .
Limitations
Due to the retrospective nature of the study, the data were observational, which limits our ability to evaluate causation, and correlation to prominent ACS risk scores for predicting outcomes such as the GRACE risk score and Thrombolysis in Myocardial Infarction (TIMI) risk score. Due to logistical reasons, data collected were of in-patients, and do not take into account the highest risk patients who expired in the emergency room (ER) prior to admission; as such, mortality rates may be underestimated. The absence of follow up data and post-discharge event rates are an additional limitation.The socio-economic status of the patients was not documented, a factor that largely influences patients' ability to finance coronary angiography and PCI, both of which are important predictive factors access to health care and consequent outcome. Also, as data was limited to the capital city where patients finance care by themselves, it may not be geographically or socioeconomically representative on the entire Bangladeshi population, in terms of risk factor and mortality rates.
Conclusion
To the best of our knowledge, this study represents one of the larger single centre analyses of ACS patients in Bangladesh thus far. Bangladeshi subjects with ACS tend to be younger, with high prevalence of cardiovascular risk factors particularlydiabetes. In-hospital mortality rates were comparable to some South and East Asian registries, but higher than those of developed countries in Europe and the Americas.Management strategies were more conservative than those reported in Western populations, and there is room for further improvement in terms of guideline-directed therapy, both pharmacotherapy and interventional, in order to improve outcomes among ACS patients.
